KRISTY DARNELL: Open Payments
NPI 1316244528 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,649 in 161 payments from 31 companies in 2025. Trend: 2023 $3,162 · 2024 $6,028 · 2025 $3,649
Food & beverage: $3,649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $527 |
| Novartis Pharmaceuticals Corporation | 29 | $397 |
| Teva Pharmaceuticals USA, Inc. | 11 | $327 |
| Biogen, Inc. | 11 | $277 |
| Amgen Inc. | 13 | $269 |
| Inspire Medical Systems, Inc. | 2 | $216 |
| Celgene Corporation | 8 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $161 |
| Lilly USA, LLC | 6 | $142 |
| Neurelis, Inc. | 5 | $139 |
Products named: KESIMPTA, TYSABRI, EVENITY, UBRELVY, AUSTEDO XR, INSPIRE, ZEPOSIA, QULIPTA.
Industry payments across IN — which companies pay providers there.
